24 May 2024 --- Biosciences company Brightseed introduces Rapid Profiling and its recently expanded Microbiome discovery programs for its partners to unlock novel health insights for product development and accelerate commercialization timelines. By adding Rapid Profiling to its partner programs, Brightseed can deliver actionable insights into ingredients’ phytochemical and bioactive composition in six to eight weeks, accelerating the clinical validation and commercialization roadmap.
